Intranasal delivery of a broadly neutralizing single domain antibody targeting ACE2 protects against SARS-CoV-2 infection
Simon Blachier, Ignacio Fernández, Laurine Conquet, Émilie Giraud, Isabelle Staropoli, Vincent Michel, Fruzsina Szilagyi, Salomé Guez, Alix Boucharlat, Jeanne Chiaravalli, Jaouen Tran-Rajau, Evelyne Dufour, Stéphane Pêtres, Delphine Planas, Xavier Montagutelli, , Anne Brelot
This paper develops a single domain antibody targeting ACE2 that protects against SARS-CoV-2 infection in mice when delivered intranasally.
bioRxiv · Oct 11, 2024 · PreprintMicrobiology